GB Sciences Inc (GBLX): GB Sciences Obtains Exclusive Worldwide...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 10/17/2017 9:07:32 AM

Tuesday, October 17, 2017 9:07:32 AM

GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain

https://www.prnewswire.com/news-releases/gb-sciences-obtains-exclusive-worldwide-license-on-a-time-released-cannabinoid-formulation-for-neuropathic-pain-300537302.html

Keep Last Read

Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM

InvestorsHub NewsWire

FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

Only $200 per official company press release!